Emmanuel Aris, PhD

Lead Real World Data & Analytics
GSK, Belgium

Disclosure(s): GSK: Employment, Stocks/Bonds (Public Company)

Poster(s):

• (P-19) The Adjuvanted Recombinant Zoster Vaccine Is Effective in Preventing Herpes Zoster (HZ) Among Patients ≥ 50 Years of Age (YOA) With Selected Autoimmune Diseases in the United States: A Real-World Database Analysis (2018–2021)
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT